InvestorsHub Logo
Followers 1
Posts 63
Boards Moderated 0
Alias Born 01/15/2019

Re: ap17 post# 14701

Thursday, 05/14/2020 4:48:03 PM

Thursday, May 14, 2020 4:48:03 PM

Post# of 22000
I thought I heard Russ Hammer, CFO, mention on the earnings call that he expects a shift to positive EBITDA in late 2020. That might be a lofty goal - they have the gross margins, but they need to slim down SG&A spending. Hammer mentioned that they should be able to leverage these investments once the FDA issues guidance on CBD in ingestible products. If they have built a solid base of fixed costs and semi-fixed costs in their SG&A structure, a significant portion of future gross profit should drop straight to the bottom line (earnings and EBITDA). That's the hope anyway.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CWBHF News